Clinical Trial Update: Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF [NA]

View source ↗

Summary

A clinical trial evaluating rate-adaptive pacing for chronotropic response in heart failure with preserved ejection fraction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure With Preserved Ejection Fraction | NA | Status: WITHDRAWN